|
EP3248605A1
(en)
|
2009-07-06 |
2017-11-29 |
Children's Hospital Medical Center |
Inhibiting inflammation with milk oligosaccharides
|
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
CN114949001A
(zh)
|
2012-08-29 |
2022-08-30 |
加州理工学院 |
孤独症谱系障碍的诊断和治疗
|
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
|
EP2885977A1
(en)
*
|
2013-12-19 |
2015-06-24 |
Agriculture and Food Development Authority (TEAGASC) |
An oligosaccharide-enriched composition having immune-modulatory and anti-adhesion properties
|
|
US20150305385A1
(en)
*
|
2014-04-25 |
2015-10-29 |
Mead Johnson Nutrition Company |
Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
|
|
PL3209673T5
(pl)
|
2014-10-24 |
2023-10-23 |
Glycom A/S |
Mieszaniny hmo
|
|
US20160346303A1
(en)
|
2014-10-29 |
2016-12-01 |
Glycom A/S |
Synthetic composition and method for treating irritable bowel syndrome
|
|
WO2016066174A1
(en)
*
|
2014-10-29 |
2016-05-06 |
Glycom A/S |
Synthetic composition and method for promoting mucosal healing
|
|
US11040049B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
|
US11040050B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
|
WO2016069801A1
(en)
*
|
2014-10-30 |
2016-05-06 |
California Institute Of Technology |
Compositions and methods comprising bacteria for improving behavior in neurodecelopmental disorders
|
|
EA201790811A1
(ru)
|
2014-10-30 |
2017-11-30 |
Калифорния Инститьют Оф Текнолоджи |
Содержащие бактерии композиции и способы для улучшения видов поведения при нарушениях неврологического развития
|
|
US10835544B2
(en)
|
2014-12-08 |
2020-11-17 |
Glycom A/S |
Synthetic composition for regulating satiety
|
|
US10987368B2
(en)
|
2014-12-08 |
2021-04-27 |
Glycom A/S |
Synthetic composition for preventing or treating CVD
|
|
US10881674B2
(en)
|
2014-12-08 |
2021-01-05 |
Glycom A/S |
Synthetic composition for treating metabolic disorders
|
|
US10828313B2
(en)
|
2014-12-08 |
2020-11-10 |
Glycom A/S |
Synthetic composition for treating metabolic disorders
|
|
AU2018205072B2
(en)
*
|
2014-12-23 |
2020-05-21 |
Cj Bioscience, Inc. |
Immune modulation
|
|
PL3193901T3
(pl)
|
2014-12-23 |
2018-10-31 |
4D Pharma Research Limited |
Polipeptyd pyrynowy i immunomodulacja
|
|
CN113862175A
(zh)
|
2014-12-23 |
2021-12-31 |
4D制药研究有限公司 |
免疫调控
|
|
US10857167B2
(en)
|
2015-04-28 |
2020-12-08 |
Children's Hospital Medical Center |
Use of oligosaccharide compositions to enhance weight gain
|
|
PE20180267A1
(es)
|
2015-06-15 |
2018-02-06 |
4D Pharma Res Ltd |
Composiciones que comprenden cepas bacterianas
|
|
RS59446B1
(sr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Blautia stercosis i wexlerae za upotrebu u lečenju inflamatornih i autoimunskih bolesti
|
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
MD3206700T2
(ro)
|
2015-06-15 |
2019-12-31 |
4D Pharma Res Ltd |
Compoziții conținând tulpini bacteriene
|
|
PL3368046T3
(pl)
|
2015-10-28 |
2022-11-28 |
Glycom A/S |
Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania
|
|
WO2017071716A1
(en)
|
2015-10-28 |
2017-05-04 |
Glycom A/S |
Synthetic composition and method for modulating emotion and mood disorders
|
|
WO2017084673A1
(en)
*
|
2015-11-17 |
2017-05-26 |
Glycom A/S |
Synthetic Composition for Treating Antibiotic Associated Complications
|
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
WO2017085520A1
(en)
|
2015-11-20 |
2017-05-26 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
MY186217A
(en)
|
2015-12-15 |
2021-06-30 |
Nestle Sa |
Mixture of hmos
|
|
JP6441536B2
(ja)
|
2016-03-04 |
2018-12-19 |
フォーディー ファーマ ピーエルシー4D Pharma Plc |
細菌株を含む組成物
|
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
CA3016911A1
(en)
*
|
2016-03-14 |
2017-09-21 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
|
ES2938355T3
(es)
*
|
2016-05-05 |
2023-04-10 |
Glycom As |
Composición que comprende HMOS para el tratamiento de la diarrea no infecciosa
|
|
WO2017198276A1
(en)
|
2016-05-19 |
2017-11-23 |
Glycom A/S |
Synthetic composition
|
|
EP3478093A4
(en)
*
|
2016-07-01 |
2020-03-04 |
Evolve Biosystems, Inc. |
METHOD FOR ELEVATING THE MATURATION OF THE MAMMAL IMMUNE SYSTEM
|
|
TW201821093A
(zh)
|
2016-07-13 |
2018-06-16 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
|
CN109715169A
(zh)
|
2016-07-28 |
2019-05-03 |
方塔拉合作集团有限公司 |
乳制品和工艺
|
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
CA3048669A1
(en)
|
2016-12-15 |
2018-06-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for modulating growth of a genetically modified gut bacterial cell
|
|
KR102019364B1
(ko)
*
|
2017-02-27 |
2019-09-06 |
한국생명공학연구원 |
시아릴락토오스를 유효성분으로 포함하는 항균용 조성물
|
|
JP2020513014A
(ja)
*
|
2017-04-07 |
2020-04-30 |
チルドレンズ ホスピタル メディカル センター |
2’−フコシルラクトース化合物による炎症性腸疾患の治療
|
|
HUE054164T2
(hu)
|
2017-05-22 |
2021-08-30 |
4D Pharma Res Ltd |
Baktériumtörzseket tartalmazó készítmények
|
|
WO2018215782A1
(en)
|
2017-05-24 |
2018-11-29 |
4D Pharma Research Limited |
Compositions comprising bacterial strain
|
|
MA49010B1
(fr)
|
2017-06-14 |
2020-11-30 |
4D Pharma Res Ltd |
Compositions comprenant une souche bactérienne du genre megasphaera et leurs utilisations
|
|
SMT202000695T1
(it)
|
2017-06-14 |
2021-01-05 |
4D Pharma Res Limited |
Composizioni comprendenti ceppi batterici
|
|
LT3600363T
(lt)
|
2017-06-14 |
2021-02-10 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterijų kamienus
|
|
MX2020004133A
(es)
*
|
2017-10-04 |
2020-08-13 |
Univ California |
Oligosacaridos inmunomoduladores.
|
|
WO2019106620A1
(en)
*
|
2017-11-30 |
2019-06-06 |
Glycom A/S |
Human milk oligosaccharides and synthetic compositions thereof for microbiota modulation
|
|
US11304966B2
(en)
|
2017-12-22 |
2022-04-19 |
Glycom A/S |
Composition comprising HMOs for preventing or reducing nociception
|
|
CA3093384A1
(en)
*
|
2018-03-08 |
2019-09-12 |
Plexus Worldwide Llc |
Compositions and methods for skin renewal
|
|
CN108935698A
(zh)
*
|
2018-09-11 |
2018-12-07 |
内蒙古伊利实业集团股份有限公司 |
一种预防小儿腹泻疾病的营养组合物及应用
|
|
BE1027078A9
(nl)
*
|
2019-02-25 |
2020-09-28 |
Nutribam Bvba |
Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
|
|
ES3036228T3
(en)
|
2019-02-25 |
2025-09-16 |
Nutribam Bv |
Composition comprising human milk oligosaccharide for use in supporting and/or improving intestinal health
|
|
CN110257299B
(zh)
*
|
2019-07-11 |
2022-06-10 |
锦州医科大学 |
一种阴沟肠杆菌在促进反刍动物生长的应用
|
|
CN118020940A
(zh)
*
|
2019-11-29 |
2024-05-14 |
内蒙古伊利实业集团股份有限公司 |
副干酪乳杆菌k56提升肠道细菌感染抗性和肠道免疫力的应用
|
|
JP7474596B2
(ja)
*
|
2020-01-20 |
2024-04-25 |
森永乳業株式会社 |
新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物
|
|
CN111363671B
(zh)
*
|
2020-02-26 |
2023-07-21 |
天津医科大学 |
一种肠道厌氧微生物培养瓶及其制备方法
|
|
WO2021197492A1
(zh)
*
|
2020-04-03 |
2021-10-07 |
内蒙古伊利实业集团股份有限公司 |
可提升生物体对金黄色葡萄球菌感染的抵御能力的母乳低聚糖
|
|
CN112075637B
(zh)
*
|
2020-04-27 |
2023-05-23 |
合生元(广州)健康产品有限公司 |
一种减少肠道气体产生的组合物
|
|
CN112841543A
(zh)
*
|
2021-01-28 |
2021-05-28 |
重庆周师兄餐饮文化有限公司 |
一种麻辣脆的加工方法
|
|
US20240306690A1
(en)
|
2021-01-29 |
2024-09-19 |
Societe Des Produits Nestle S.A. |
Mixture of hmos and bifidobacteria
|
|
CN112890200B
(zh)
*
|
2021-03-08 |
2021-11-12 |
合生元(广州)健康产品有限公司 |
用于促进低体重婴幼儿生长追赶的一种营养组合物
|
|
WO2022223430A1
(en)
*
|
2021-04-19 |
2022-10-27 |
Dsm Ip Assets B.V. |
A composition of enzymes and human milk oligosaccharides
|
|
EP4366552A1
(en)
*
|
2021-07-09 |
2024-05-15 |
Société des Produits Nestlé S.A. |
Uses of bifidobacterium longum transitional microorganism
|
|
CN113796545B
(zh)
*
|
2021-09-13 |
2022-09-13 |
合生元(广州)健康产品有限公司 |
调节肠道免疫功能的母乳低聚糖组合物及其应用
|
|
KR102411242B1
(ko)
*
|
2021-10-18 |
2022-06-22 |
큐티스바이오 주식회사 |
클렙시엘라 아에로제네스의 피부 상태 개선 용도
|
|
DK202200588A1
(en)
|
2022-06-20 |
2024-02-23 |
Dsm Ip Assets Bv |
Mixture of fucosylated HMOs
|
|
CN115920013A
(zh)
*
|
2022-11-15 |
2023-04-07 |
合生元(广州)健康产品有限公司 |
乳源成分在降低单增李斯特菌引起的感染风险中的应用
|
|
CN116042486B
(zh)
*
|
2023-02-22 |
2024-11-08 |
高邮市人民医院 |
一种用于治疗动脉粥样硬化的复合菌制剂
|